Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.72% | $13.85M | €450.67B | 61.10% | 76 Outperform | |
| Roche Holding AG | 1.58% | $8.08M | CHF287.79B | 42.71% | 73 Outperform | |
| AstraZeneca | 1.53% | $7.80M | £231.12B | 29.12% | 80 Outperform | |
| HSBC Holdings | 1.50% | $7.63M | £217.54B | 42.42% | 80 Outperform | |
| Novartis AG | 1.48% | $7.55M | CHF235.62B | 31.22% | 80 Outperform | |
| Nestlé SA | 1.27% | $6.50M | CHF200.67B | 13.36% | 71 Outperform | |
| Siemens | 1.13% | $5.75M | €200.53B | 11.12% | 74 Outperform | |
| Toyota Motor | 1.12% | $5.71M | ¥48.29T | 34.78% | 80 Outperform | |
| Mitsubishi UFJ Financial Group | 1.11% | $5.64M | ¥34.50T | 66.43% | 76 Outperform | |
| SAP SE | 1.02% | $5.21M | €193.22B | -38.11% | 66 Neutral |